Long‐term outcomes of avascular necrosis in sickle cell disease using joint‐specific patient‐reported outcome measures: Results from a multicentre study
British Journal of Haematology · 2025
DOI: 10.1111/bjh.19802 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift British Journal of Haematology, 2025. Verfasst von Maddalena Casale und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Woman, Child and General and Specialized Surgery, University of Campania 'Luigi Vanvitelli', Naples, Italy. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Patient Reported Outcome Measures, Osteonecrosis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: ASH Foundation.
Abstract (Originalsprache)
Avascular necrosis (AVN) is a prevalent and progressive complication in young patients with sickle cell disease (SCD), but no study evaluated the long‐term subjective and objective outcome measures. Oxford hip score (OHS) and Oxford shoulder scores (OSS) are validated joint‐specific patient‐reported outcome measures (PROMs). In this prospective multicentre study, 47 SCD patients with pre‐existing diagnosis of AVN occurred at a median age of 35.9 (24.2–47.6) filled out the OHS and OSS at median follow‐up of 9.4 years (4.5–12.9). No patient died after diagnosis of AVN. Hip AVN was present in 34 (72%) patients, with bilateral involvement in 25 (74%); 26 (59%) underwent total hip arthroplasty (THA) at a median age of 34.6 (22.6–49.5); and 4 (15%) required re‐surgery. OHS revealed moderate to severe impairment both in patients underwent THA and no hip surgery. Shoulder AVN was present in 13 (6%) patients and OSS revealed mild to moderate impairment. A high rate of compromised joint function and pain was observed 10 years after diagnosis of AVN regardless of the type of treatment, outlying the need to improve the management of this sickle‐related complication. OHS and OSS are validated joint‐specific PROMs easy to use in all SCD centres.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Woman, Child and General and Specialized Surgery, University of Campania 'Luigi Vanvitelli', Naples, Italy.
- Department of Medical and Surgical Specialties and Dentistry, University of Campania 'Luigi Vanvitelli', Naples, Italy.
- Thalassemia Centre, Hospital Vittorio Emanuele, Gela, Italy.
- Talassemia Unit, AOU Policlinico G.Rodolico-San Marco di Catania, Catania, Italy.
- Thalassemia Centre, Hospital "Giovanni Paolo II" Ragusa, Ragusa, Italy.
- Pediatric Oncology-Hematology, Hospital of Perugia, Perugia, Italy.
ORCID-Profile: Maddalena Casale
Förderung
- ASH Foundation
Zitieren
APA
Casale, M., Toro, G., Porcelli, F., Quota, A., Rosso, R., Spadola, V., Arcioni, F., Campisi, S., Roberti, D., & Perrotta, S. (2025). Long‐term outcomes of avascular necrosis in sickle cell disease using joint‐specific patient‐reported outcome measures: Results from a multicentre study. British Journal of Haematology. https://doi.org/10.1111/bjh.19802
Vancouver
Casale M, Toro G, Porcelli F, Quota A, Rosso R, Spadola V, et al. Long‐term outcomes of avascular necrosis in sickle cell disease using joint‐specific patient‐reported outcome measures: Results from a multicentre study. British Journal of Haematology. 2025. doi:10.1111/bjh.19802
BibTeX
@article{Casale2025,
author = {Casale, Maddalena and Toro, Giuseppe and Porcelli, Federica and Quota, Alessandra and Rosso, Rosamaria and Spadola, Vincenzo and Arcioni, Francesco and Campisi, Saveria and Roberti, Domenico and Perrotta, Silverio},
title = {Long‐term outcomes of avascular necrosis in sickle cell disease using joint‐specific patient‐reported outcome measures: Results from a multicentre study},
journal = {British Journal of Haematology},
year = {2025},
doi = {10.1111/bjh.19802}
}
EUVIMED